Injectable carrier formulations of hyaluronic acid...

Details Injectable carrier formulations of hyaluronic acid... Injectable carrier formulations of hyaluronic acid...

2007-01-18

2009-10-27

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07608580

ABSTRACT:
An injectable formulation is disclosed for delivery of osteogenic proteins. The formulation comprises a pharmaceutically acceptable admixture of an osteogenic protein; and formulations comprising osteogenic protein, hyaluronic acid derivatives and tricalcium phosphate are also disclosed. Methods for formulating porous injectable gels and pastes from hyaluronic acid are also disclosed.

REFERENCES:
patent: 3955719 (1976-05-01), Pheulpin
patent: 4758233 (1988-07-01), Phillips et al.
patent: 4784055 (1988-11-01), Langen et al.
patent: 4851521 (1989-07-01), della Valle et al.
patent: 4957744 (1990-09-01), della Valle et al.
patent: 5118667 (1992-06-01), Adams et al.
patent: 5124316 (1992-06-01), Antoniades et al.
patent: 5290271 (1994-03-01), Jernberg
patent: 5308889 (1994-05-01), Rhee et al.
patent: 5324775 (1994-06-01), Rhee et al.
patent: 5328955 (1994-07-01), Rhee et al.
patent: 5336767 (1994-08-01), della Valle et al.
patent: 5352715 (1994-10-01), Wallace et al.
patent: 5356629 (1994-10-01), Sander et al.
patent: 5413989 (1995-05-01), Ogawa et al.
patent: 5422340 (1995-06-01), Ammann et al.
patent: 5464440 (1995-11-01), Johansson
patent: 5510121 (1996-04-01), Rhee et al.
patent: 5645592 (1997-07-01), Nicolais et al.
patent: 5658882 (1997-08-01), Celeste et al.
patent: 5752974 (1998-05-01), Rhee et al.
patent: 5935594 (1999-08-01), Ringeisen et al.
patent: 5939323 (1999-08-01), Valentini et al.
patent: 5942499 (1999-08-01), Radomsky
patent: 6132214 (2000-10-01), Suhonen et al.
patent: 6187742 (2001-02-01), Wozney et al.
patent: 6699471 (2004-03-01), Radice et al.
patent: 7189392 (2007-03-01), Kim et al.
patent: 283073 (1997-12-01), None
patent: 2000-202024 (2000-07-01), None
patent: WO 91/17777 (1991-11-01), None
patent: WO 93/20858 (1993-10-01), None
patent: WO 97/32591 (1997-09-01), None
patent: WO 97/45532 (1997-12-01), None
patent: WO 97/49412 (1997-12-01), None
patent: WO 99/24070 (1999-05-01), None
patent: WO 00/16818 (2000-03-01), None
patent: WO 00/37124 (2000-06-01), None
patent: WO 02/43759 (2002-06-01), None
Fleisch, Bisphosphonates In Disease, From the Laboratory to the Patient, 3rd Ed. Parthenon Publishing (1997).
International Search Report for PCT/US00/28468.
Notice of Revocation of EP1223990.
Aigner et al., “Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester,” J Biomed Mater Res 42:172-181 (1988).
Bonucci et al., “Prevention of Ovariectomy Osteopenia in Rats after Vaginal Administration of Hyaff 11 Microspheres Containing Salmon Calcitonin,” Calcif Tissue Int 56:274-279 (1995).
Brun et al., “Chondrocyte aggregation and reorganization into three-dimensional scaffolds,” J Biomed Mat Res 46:337-46 (1999).
Campoccia et al., “Semisynthetic resorbable materials from hyaluronan esterification,” Biomaterials, 19:2101-27 (1998).
Ghezzo et al., “Hyaluronane derivative microspheres as NGF delivery devices: Preparation methods and in vitro release characterization,” Int J Pharmaceutics 87:21-29 (1992).
Illum et al., “Hyaluronic acid ester microspheres as a nasal delivery system for insulin,” J Controlled Release 29(1-2):133-141 (1994).
Kubler et al., “Bone Morphogenetic Protein-Mediated Interaction of Periosteum and Diaphysis,” Clin Osteoped Rel Res 258:279-94 (1990).
Solchaga et al., “Hyaluronic Acid-Based Polymers as Cell Carriers for Tissue-Engineered Repair of Bone and Cartilage,” J Orthopaedic Res 17:205-213 (1999).
Urist et al., “Bone Regeneration under the Influence of a Bone Morphogenetic Protein (BMP) Beta Tricalcium Phosphate (TCP) Composite in Skull Trephine Defects in Dogs,” Clin. Orthoped. Rel. Res., 214:295-304 (1986).
Urist et al., β-tricalcium Phosphate Delivery System for Bone Morphogenetic Protein, Clin. Orthoped. Related Res., 187:227-280 (1984).
Vercruysse et al., “Hyaluronate Derivatives in Drug Delivery,” Crit Revs Ther Drug Carriers 15(5):513-15 (1997).

Affiliated with

Also associated with

Rating

Injectable carrier formulations of hyaluronic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Injectable carrier formulations of hyaluronic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable carrier formulations of hyaluronic acid... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4064736